Suboxone (buprenorphine/naloxone)

Suboxone is the closest thing we have to a miracle drug in psychiatry, and most of the people who need it spent years being talked out of taking it by family, friends, sponsors, and sometimes even by other clinicians who didn’t understand what it actually does. It’s buprenorphine, a partial opioid agonist (a drug that binds to opioid receptors but only partially activates them), combined with naloxone, which is in there to discourage anybody from crushing the pill and injecting it. For opioid use disorder, Suboxone is the standard of care, full stop. Methadone is the other established option and we’ll get to that, but for most outpatient patients in Oregon and Washington, Suboxone is where the conversation starts.

The X-waiver is gone, by the way, which is the regulatory news that should have been a bigger deal than it was. Used to be that only specially-trained, specially-registered prescribers could write buprenorphine. As of 2023 that requirement went away, which means any prescriber with a DEA number can write it. We still don’t have nearly enough prescribers willing to actually do it, but the regulatory bottleneck is finally off and that’s worth saying out loud.

What it actually does

Buprenorphine binds tightly to the same receptors that heroin, oxycodone, and fentanyl bind to, but only partially activates them. So you don’t get high. You don’t get the rush, you don’t get the nod, you don’t get the warm-blanket feeling that turned the whole thing into a problem in the first place. What you get is the absence of withdrawal and the absence of craving, which if you’ve been in active addiction is the only two things you actually want at this point. The high stopped being the point a long time ago. By the time someone’s asking about Suboxone, they’re just trying to not feel like death.

It also has a ceiling effect, which is the safety part. At a certain dose (somewhere around 24mg for most people), taking more buprenorphine doesn’t do more. The receptors are saturated and additional drug doesn’t translate into additional effect. You can’t really overdose on buprenorphine alone the way you can on full agonists like fentanyl or heroin or oxycodone. Mix it with benzos (benzodiazepines, the Xanax and Klonopin family) or alcohol or other sedatives and the math gets uglier, but on its own buprenorphine is about as safe as opioid drugs get.

Induction is the awkward part

Here’s the thing nobody warns patients about clearly enough. You have to be in withdrawal to start Suboxone. If you take the first dose while there’s still a meaningful amount of a full agonist on your receptors, the buprenorphine kicks the other drug off the receptor and replaces it partially. What you get is precipitated withdrawal, which is the worst thirty minutes of your life, and it’s the reason a lot of people decide Suboxone “didn’t work” and walk away from the treatment that could have saved their life.

The protocol is: stop the opioid you’re using, wait until you’re in moderate withdrawal (sweating, gooseflesh, runny nose, gut cramping, restless, miserable, the works), then take the first dose. Twelve to twenty-four hours after the last short-acting opioid, longer if you’re coming off methadone or fentanyl. Fentanyl in particular is its own animal because it sits in fat tissue and keeps releasing into your system for days after the last use. We sometimes have to use a micro-induction approach where we layer tiny doses on top of continued fentanyl use over a week so the buprenorphine builds up gradually instead of kicking the fentanyl off the receptors all at once. If you’re a fentanyl user, tell whoever is inducting you. The standard protocol doesn’t work the same and the standard protocol getting used on a fentanyl user is the most common way somebody concludes Suboxone is impossible.

What to expect at home

Most patients are stable on somewhere between 8 and 24 mg a day, dosed once daily or split between morning and night. The first week feels weird… not high, not bad, just slightly out of it, slightly off, like a low-grade flu that’s lifting in slow motion. Some people feel a little out of it the first few days and that fades. Constipation is real and persistent, treat it from day one with stool softeners and fiber or you’ll regret it pretty quickly. Sleep can be janky for the first couple weeks while your body re-learns how to do it without an opioid running through it.

After that, most patients forget they’re on it. It’s a tab that dissolves under the tongue once a day. That’s the whole thing. The wife doesn’t have to manage it, the boss doesn’t have to know, you don’t have to show up at a clinic at 6 AM the way methadone requires. It sits in your medicine cabinet next to the multivitamin and the blood pressure pill and you take it with the rest of your morning routine.

What’s nice to hear when it works

The before-and-after on Suboxone is one of the more dramatic things in psychiatry, and it gets undersold because the field is squeamish about calling a medication for opioid use disorder a success story. The pattern is: somebody who’s been in active addiction for years, who lost a job or a marriage or a relationship with their kids, who’s been chasing the next dose every six hours just to not feel sick, gets on the medication and within a week the craving is gone and the chasing is over. Not the addiction, not the underlying psychology, not the wreckage of the years before. Just the brutal, hour-by-hour, body-running-the-show part of it.

And what that opens up is everything else. The patient can think about something other than the next dose. The patient can hold down a job again because his day isn’t structured around finding pills. The patient can sit across from his wife at dinner without his brain calculating how long until withdrawal kicks in. The actual life can resume. That’s not a small thing, that’s most of the point, and the data backs it up: medication-assisted treatment cuts opioid-related mortality by more than half compared to abstinence-only treatment. Half. That’s not a small effect size in a field where most effect sizes are modest.

The pattern that shows up most

The story that walks in the door more often than any other goes something like this: picture a guy who hurt his back on a job in his twenties or early thirties, got six months of oxycodone, then six more months, then his prescriber retired or got investigated or just stopped refilling. So he started buying pills from somebody, then started buying heroin because pills got expensive, then started using fentanyl because that’s all there was once 2020 hit. Somewhere in there he lost the marriage, lost the lead position at work, kept showing up to the job site somehow. Eventually his mom or his wife or his brother drove him in.

The induction takes a few days for fentanyl users, longer micro-protocol or shorter standard one depending on the substance. He’s on 16mg of Suboxone by the end of week one. He’s got a job again three months later, sometimes the same job, sometimes a different one. He’s been on the medication for years and we periodically talk about tapering and he doesn’t want to taper, and nobody pushes him to, because the relapse rate when people come off this stuff is brutal and the drug is sitting there working and he’s living his life. The right amount of Suboxone is the amount that keeps you living your life. Trying to find a lower amount because the number on the bottle feels symbolic is a bad reason to risk what got rebuilt.

The high stopped being the point a long time ago. By the time someone’s asking about Suboxone, they’re just trying to not feel like death.

The stigma is the dumbest part

You will encounter people, including some in recovery, who tell you Suboxone isn’t “real” recovery because you’re still on an opioid. Those people are working off bad information and the data is unambiguous on the point. Medication-assisted treatment cuts mortality by more than half compared to abstinence-only treatment. We’re talking about whether you live or die. Nobody judges a diabetic for taking insulin. Nobody judges somebody with high blood pressure for taking lisinopril every morning. Opioid use disorder is a chronic medical condition with a medication that treats it, and the only reason there’s stigma is because the disease used to be called “being a junkie” and the moral framing hasn’t fully caught up to the medical one.

Twelve-step programs have done a lot of good for a lot of people and the abstinence-only stance against medication-assisted treatment is the one place where the data and the program diverge sharply. If your sponsor tells you Suboxone isn’t real sobriety, your sponsor is wrong about that specific thing, and you can value the rest of the program without accepting that particular position. The two aren’t a package deal.

Where I land on medication, and where you land is up to you

The autonomy piece on Suboxone is straightforward. If you’ve got opioid use disorder and you want the medication, you get the medication. Hardly any prescriber should be saying no to this, and the ones who do are usually saying no because of their own discomfort with the medication-assisted framing, not because of any clinical reason that holds up. The prescription gets filled and the conversation continues from there. The work isn’t the medication, the work is what becomes possible once the medication is doing its part.

If you want to talk about tapering eventually, that’s a conversation, not a refusal. Some patients do successfully taper after years of stability and stay sober. Others taper and relapse and come back on the medication. The data says people who stay on longer do better, but data is for populations and the patient in front of me is a person making a choice about his own life. The honest take goes on the table. The choice is yours.

What not to do

Don’t combine it with benzos without a prescriber knowing. The respiratory depression risk goes up substantially. If you’re on a benzo for legitimate reasons, that’s a conversation about whether the benzo can come off or be tapered down. Just don’t combine them silently and assume it’s fine.

Don’t try to get high on top of it. Some patients try this in the first few weeks, taking heroin or fentanyl on top of the Suboxone, and the math is bad on multiple levels. The buprenorphine blocks the high so you don’t get the effect you were chasing, you get less of it for more money, and the overdose risk on the full agonist goes up because you’re using more of it trying to get past the block. Bad strategy for everybody involved.

Don’t stop it abruptly because you’re feeling fine and you forget to refill. That’s how relapses happen. Set the prescription to auto-refill and pick it up before you run out. The Suboxone working in the background isn’t proof you don’t need it, it’s evidence that it’s doing its job.

Bottom line

If you’ve got opioid use disorder, Suboxone is the move. The induction is awkward, the first week is weird, and after that the drug mostly runs in the background while you get your life back. If somebody tells you that taking it means you’re not really sober, ignore them, they’re working off bad information, and you’re trying to not die. That’s not a hard math problem. The medication is the floor under everything else you’re going to build.

Sources

1. Sordo L, Barrio G, Bravo MJ, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550. PMID 28446428.
2. Wakeman SE, Larochelle MR, Ameli O, et al. Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Netw Open. 2020;3(2):e1920622. PMID 32022884.
3. Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;(2):CD002207. PMID 24500948.